Target Name: ZNF595
NCBI ID: G152687
Review Report on ZNF595 Target / Biomarker Content of Review Report on ZNF595 Target / Biomarker
ZNF595
Other Name(s): FLJ31740 | ZN595_HUMAN | zinc finger protein 595 | Zinc finger protein 595

ZNF595: A Potential Drug Target Or Biomarker

ZNF595 (FLJ31740) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the Zinc finger gene family (ZNF), which is a group of non-coding RNA -binding proteins that play a crucial role in various cellular processes. ZNF595 is one of the proteins that encodes byproducts of ZNF5 gene, which is located on chromosome 16.

The ZNF gene family has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The ZNF5 gene has been shown to be involved in the regulation of cell proliferation, differentiation, and survival. The loss of ZNF5 has been linked to the development of certain diseases, including neurofibromatosis, a genetic disorder that causes the growth of undifferentiated cells that can lead to the formation of tumors.

ZNF595 is a 21-kDa protein that contains 106 amino acid residues. It has a characteristic ZNF5 gene family structure, with a N-terminal ZNF5 domain, a central transmembrane domain, and a C-terminal T-loop domain. The ZNF5 domain is composed of a series of conserved amino acid residues that are involved in the formation of a nucleotide-binding oligomerization domain (NBO domain) and a zinc finger domain. The NBO domain is a unique feature of ZNF595 that is responsible for its binding to various nucleic acids, including DNA and RNA.

ZNF595 has been shown to play a role in various cellular processes, including cell growth, differentiation, and survival. It has been shown to be involved in the regulation of cell proliferation, cell survival, and cell migration. For example, studies have shown that overexpression of ZNF595 can promote the growth of cancer cells, while inhibition of ZNF595 has been shown to inhibit the growth of cancer cells.

In addition to its role in cell survival, ZNF595 has also been shown to play a role in the regulation of cellular processes that are important for brain development and function. For example, studies have shown that ZNF595 is involved in the regulation of neuron survival and differentiation in the brain. It has been shown to interact with various brain-derived neurotrophic factor (BDNF) proteins, which are involved in the maintenance of brain cells and the regulation of brain development.

Given the involvement of ZNF595 in various cellular processes, it is a potential drug target or biomarker for a variety of diseases. For example, ZNF595 has been shown to be involved in the regulation of cancer cell growth, which makes it a potential target for anti- -cancer drugs. In addition, ZNF595 has been shown to play a role in the regulation of neuron survival and differentiation in the brain, which makes it a potential target for drugs that are aimed at promoting brain health and function.

In conclusion, ZNF595 is a protein that has been shown to play a role in various cellular processes, including cell growth, differentiation, and survival. Its unique ZNF5 gene family structure and its involvement in the regulation of brain development and function make it a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of ZNF595 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Zinc Finger Protein 595

Functions: May be involved in transcriptional regulation

The "ZNF595 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF595 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710